Cytotoxic agents comprising taxanes and their therapeutic use
A cytotoxic agent comprising one or more taxanes linked to a cell binding agent. A therapeutic composition for killing selected cell populations comprising: (A) a cytotoxic amount of one or more taxanes covalently bonded to a cell binding agent through a linking group, and (B) a pharmaceutically acceptable carrier, diluent or excipient. A method for killing selected cell populations comprising contacting target cells or tissue containing target cells with an effective amount of a cytotoxic agent comprising one or more taxanes linked to a cell binding agent. Novel sulfur-containing taxanes.
1. A compound represented by formula (I):
wherein: R 1 , R 1 ′ and R 1 ″ are the same or different and are H, —F, —NO 2 , —CN, —Cl, —CHF 2 , —CF 3 , —NR 7 R 8 or —OR 9 wherein R 7 and R 8 are the same or different and are linear alkyl having 1 to 10 carbon atoms, branched or cyclic alkyl having 3 to 10 carbon atoms, or simple or substituted phenyl or naphthyl, and R 9 is linear alkyl having 1 to 10 carbon atoms, or branched or cyclic alkyl having 3 to 10 carbon atoms;
R 2 together with the oxygen atom at the C-10 position forms a linear ester having from 1 to 10 carbon atoms, or a branched or cyclic ester having from 3 to 10 carbon atoms, R 3 is aryl, linear alkyl having 1 to 10 carbon atoms, or branched or cyclic alkyl having 3 to 10 carbon atoms; R 4 is —OC(CH 3 ) 3 or phenyl; R 5 is H,
R 6 is —(CH 2 ) n SZ, —CO(CH 2 ) n SZ, —(CH 2 ) n CH (CH 3 )SZ, —CO(CH 2 ) n CH(CH 3 )SZ, —(CH 2 ) n C(CH 3 ) 2 SZ, —CO(CH 2 ) n C(CH 3 ) 2 SZ, —CONR 12 (CH 2 ) n SZ, —CONR 12 (CH 2 ) n CH(CH 3 )SZ, —CONR 12 (CH 2 ) n C(CH 3 ) 2 SZ, —CO-morpholino-XSZ, -CO-piperazino-XSZ, —CO-piperidino-XSZ, or —CO-N-methylpiperazino-XSZ, wherein Z is H or SR, wherein R and R 12 are the same or different and are linear alkyl having 1 to 10 carbon atoms, branched or cyclic alkyl having 3 to 10 carbon atoms, or simple or substituted phenyl, naphthyl or heterocyclic, and R 12 in addition can be H, X is linear alkyl having 1–10 carbon atoms or branched alkyl having 3–10 carbon atoms, and n is an integer of 10.
2. The compound of claim 1 , wherein R 7 and R 8 each has 1 to 4 carbon atoms.
3. The compound of claim 1 , wherein R 7 and R 8 are the same.
4. The compound of claim 1 , wherein R 1 is the meta position.
5. The compound of claim 1 , wherein R 1 ′ and R 1 ″ are H.
6. The compound of claim 1 , wherein R 1 is —OCH 3 , R 1 ′ is —OCH 3 , and R 1 ″ is H.